Pre-S1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus

Journal of Virology

Volumn 77, Issue 17, 2003, Pages 9511-9521

  Glebe, Dieter ^a   Aliakbari, Mehriar ^a   Krass, Peter ^a   Knoop, Eva V ^a   Valerius, Klaus P ^a   Gerlich, Wolfram H ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CIRCULAR DNA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS E ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MA18 7; NEUTRALIZING ANTIBODY; PRE S1 ANTIGEN; PRE S2 ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; COVALENT BOND; HEPATITIS B VIRUS; HOST PATHOGEN INTERACTION; HOST SUSCEPTIBILITY; HUMAN; INSECTIVORE; LIVER CELL CULTURE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; TUPAIA BELANGERI; VIRUS CULTURE; VIRUS INFECTION; VIRUS ISOLATION; VIRUS PARTICLE;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; DNA, VIRAL; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; KINETICS; NEUTRALIZATION TESTS; PROTEIN PRECURSORS; TUPAIA; VIRUS REPLICATION;

EID: 0042389550     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.17.9511-9521.2003     Document Type: Article

References (54)

1. Aldrich, C. E., L. Coates, T. T. Wu, J. Newbold, B. C. Tennant, J. Summers, C. Seeger, and W. S. Mason. 1989. In vitro infection of woodchuck hepatocytes with woodchuck hepatitis virus and ground squirrel hepatitis virus. Virology 172:247-252.
2. Bruss, V., X. Lu, R. Thomssen, and W. H. Gerlich. 1994. Post-translational alterations in transmembrane topology of the hepatitis B virus large envelope protein. EMBO J. 13:2273-2279.
3. Chouteau, P., J. Le Seyec, I. Cannie, M. Nassal, C. Guguen-Guillouzo, and P. Gripon. 2001. A short N-proximal region in the large envelope protein harbors a determinant that contributes to the species specificity of human hepatitis B virus. J. Virol. 75:11565-11572.
4. Cooreman, M. P., G. Leroux-Roels, and W. P. Paulij. 2001. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J. Biomed. Sci. 8:237-247.
5. Dandri, M., M. R. Burda, E. Torok, J. M. Pollok, A. Iwanska, G. Sommer, X. Rogiers, C. E. Rogler, S. Gupta, H. Will, H. Greten, and J. Petersen. 2001. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology 33:981-988.
6. Fernholz, D., P. R. Galle, M. Stemler, M. Brunetto, F. Bonino, and H. Will, 1993. Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier. Virology 194:137-148.
7. Galle, P. R., J. Hagelstein, B. Kommerell, M. Volkmann, P. Schranz, and H. Zentgraf. 1994. In vitro experimental infection of primary human hepatocytes with hepatitis B virus. Gastroenterology 106:664-673.
8. Gerlich, W., and R. Thomssen. 1975. Standardized detection of hepatitis B surface antigen: determination of its serum concentration in weight units per volume. Dev. Biol. Stand. 30:78-87.
9. Gerlich, W. H., U. Wend, and D. Glebe. Quantitative assay of hepatitis B surface antigen in serum or plasma using Laurell electrophoresis. In R. Hamatake and J. Y. N. Lau (ed.), Hepatitis B protocols, in press. The Humana Press Inc., Totowa, N.J.
10. Germaschewski, V., and K. Murray. 1995. Screening a monoclonal antibody with a fusion-phage display library shows a discontinuity in a linear epitope within PreS1 of hepatitis B virus. J. Med. Virol. 45:300-305.
11. Glebe, D., and W. H. Gerlich. Study of the endocytosis and intracellular localization of subviral particles of HBV in primary hepatocytes. In R. Hamatake and J. Y. N. Lau (ed.), Hepatitis B protocols, in press. The Humana Press Inc., Totowa, N.J.
12. Gripon, P., C. Diot, N. Theze, I. Fourel, O. Loreal, C. Brechot, and C. Guguen-Guillouzo. 1988. Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. J. Virol. 62:4136-4143.
13. Gripon, P., S. Rumin, S. Urban, J. Le Seyec, D. Glaise, I. Cannie, C. Guyomard, J. Lucas, C. Trepo, and C. Guguen-Guillouzo. 2002. Infection of a human hepatoma cell line by hepatitis B virus. Proc. Natl. Acad. Sci. USA 99:15655-15660.
14. Guidotti, L. G., B. Matzke, H. Schaller, and F. V. Chisari. 1995. High-level hepatitis B virus replication in transgenic mice. J. Virol. 69:6158-6169.
15. Heermann, K. H., W. H. Gerlich, M. Chudy, S. Schaefer, R. Thomssen, et. al. 1999. Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. J. Clin. Microbiol. 37:68-73.
16. Heermann, K. H., U. Goldmann, W. Schwartz, T. Seyffarth, H. Baumgarten, and W. H. Gerlich. 1984. Large surface proteins of hepatitis B virus containing the pre-s sequence. J. Virol. 52:396-402.
17. Heermann, K. H., F. Waldeck, and W. H. Gerlich. 1988. Interaction between native human serum and the preS2 domain of hepatitis B virus surface antigen, p. 697-700. In A. J. Zuckermann (ed.), Viral hepatitis and liver disase. Alan R. Liss., New York, N.Y.
18. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369.
19. Ilan, E., T. Burakova, S. Dagan, O. Nussbaum, I. Lubin, R. Eren, O. Ben-Moshe, J. Arazi, S. Berr, L. Neville, L. Yuen, T. S. Mansour, J. Gillard, A. Eid, O. Jurim, D. Shouval, Y. Reisner, and E. Galun. 1999. The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents. Hepatology 29:553-562.
20. Itoh, Y., E. Takai, H. Ohnuma, K. Kitajima, F. Tsuda, A. Machida, S. Mishiro, T. Nakamura, Y. Miyakawa, and M. Mayumi. 1986. A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proc. Natl. Acad. Sci. USA 83:9174-9178.
21. Jursch, C. A., W. H. Gerlich, D. Glebe, S. Schaefer, O. Marie, and O. Thraenhart. 2002. Molecular approaches to validate disinfectants against human hepatitis B virus. Med. Microbiol. Immunol. 190:189-197.
22. Köck, J., M. Nassal, S. MacNelly, T. F. Baumert, H. E. Blum, and F. von Weizsäcker. 2001. Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus. J. Virol. 75:5084-5089.
23. Lanford, R. E., D. Chavez, K. M. Brasky, R. B. Burns III, and R. Rico-Hesse. 1998. Isolation of a hepadnavirus from the woolly monkey, a New World primate. Proc. Natl. Acad. Sci. USA 95:5757-5761.
24. Le Seyec, J., P. Chouteau, I. Cannie, C. Guguen-Guillouzo, and P. Gripon. 1999. Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain. J. Virol. 73:2052-2057.
25. Le Seyec, J., P. Chouteau, I. Cannie, C. Guguen-Guillouzo, and P. Gripon. 1998. Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity. J. Virol. 72:5573-5578.
26. Li, Q., M. Ding, and H. Wang. 1995. The infection of hepatitis D virus in adult tupaia. Zhonghua Yi Xue Za Zhi 75:611-613, 639-640.
27. Marion, P. L., L. S. Oshiro, D. C. Regnery, G. H. Scullard, and W. S. Robinson. 1980. A virus in Beechey ground squirrels that is related to hepatitis B virus of humans. Proc. Natl. Acad. Sci. USA 77:2941-2945.
28. Martin, R. D. 1990. Primate origin and evolution: a phylogenetic reconstruction. Chapman Hall, London, United Kingdom.
29. Neurath, A. R., B. Seto, and N. Strick. 1989. Antibodies to synthetic peptides from the pres1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective. Vaccine 7:234-236.
30. Phillips, M. J. 1994. Biology and pathobiology of actin in the liver, p. 19-32. In I. M. Arias, J. L. Boyer, N. Fausto, W. B. Jakoby, and D. A. Shafritz (ed.), The liver: biology and pathobiology. Raven Press, Ltd., New York, N.Y.
31. Pillot, J., T. Poynard, A. Elias, J. Maillard, Y. Lazizi, M. Brancer, P. Dubreuil, A. Budkowska, and J. C. Chaput. 1995. Weak immunogenicity of the preS2 sequence and lack of circumventing effect on the unresponsiveness to the hepatitis B virus vaccine. Vaccine 13:289-294.
32. Pontisso, P., M. G. Ruvoletto, W. H. Gerlich, K. H. Heermann, R. Bardini, and A. Alberti. 1989. Identification of an attachment site for human liver plasma membranes on hepatitis B virus particles. Virology 173:522-530.
33. Protzer, U., and H. Schaller. 2000. Immune escape by hepatitis B viruses. Virus Genes 21:27-37.
34. Ryu, C. J., P. Gripon, H. R. Park, S. S. Park, Y. K. Kim, C. Guguen-Guillouzo, O. J. Yoo, and H. J. Hong. 1997. In vitro neutralization of hepatitis B virus by monoclonal antibodies against the viral surface antigen. J. Med. Virol. 52:226-233.
35. Saldanha, J., W. Gerlich, N. Lelie, P. Dawson, K. Heermann, and A. Heath. 2001. An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang. 80:63-71.
36. Schaefer, S., T. K. Tolle, S. Lottmann, and W. H. Gerlich. 1998. Animal models and experimental systems in hepatitis B virus research, p. 51-74. In J. Koshy and W. H. Caselmann (ed.), Hepatitis B virus. Imperial College Press, London, United Kingdom.
37. Schmitt, S., D. Glebe, K. Alving, T. K. Tolle, M. Linder, H. Geyer, D. Linder, J. Peter-Katalinic, W. H. Gerlich, and R. Geyer. 1999. Analysis of the pre-S2 N- and O-linked glycans of the M surface protein from human hepatitis B virus. J. Biol. Chem. 274:11945-11957.
38. Schmitz, J., M. Ohme, and H. Zischler. 2000. The complete mitochondrial genome of Tupaia belangeri and the phylogenetic affiliation of Scandentia to other eutherian orders. Mol. Biol. Evol. 17:1334-1343.
39. Schuster, R., W. H. Gerlich, and S. Schaefer. 2000. Induction of apoptosis by the transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary rat embryo fibroblasts. Oncogene 19:1173-1180.
40. Seglen, P. O. 1976. Preparation of isolated rat liver cells. Methods Cell Biol. 13:29-83.
41. Shapira, M. Y., E. Zeira, R. Adler, and D. Shouval. 2001. Rapid seroprotection against hepatitis B following the first dose of a Pre-S1/Pre-S2/ S vaccine. J. Hepatol. 34:123-127.
42. Sobotta, D., I. Sominskaya, J. Jansons, H. Meisel, S. Schmitt, K. H. Heermann, G. Kaluza, P. Pumpens, and W. H. Gerlich. 2000. Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype. J. Gen. Virol. 81:369-378.
43. Sominskaya, I., P. Pushko, D. Dreilina, T. Kozlovskaya, and P. Pumpen. 1992. Determination of the minimal length of preS1 epitope recognized by a monoclonal antibody which inhibits attachment of hepatitis B virus to hepatocytes. Med. Microbiol. Immunol. 181:215-226.
44. Soulie, J. C., P. Devillier, J. Santarelli, A. Goudeau, P. Vermeulen, M. Guellier, P. Saliou, A. M. Hillion, F. Tron, and J. Huchet. 1991. Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens. Vaccine 9:545-548.
45. Summers, J., J. M. Smolee, and R. Snyder. 1978. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc. Natl. Acad. Sci. USA 75:4533-4537.
46. Testut, P., C. A. Renard, O. Terradillos, L. Vitvitski-Trepo, F. Tekaia, C. Degott, J. Blake, B. Boyer, and M. A. Buendia. 1996. A new hepadnavirus endemic in arctic ground squirrels in Alaska. J. Virol. 70:4210-4219.
47. Thung, S. N., and M. A. Gerber. 1981. Presence of receptors for polymerized albumin in HBsAg-containing hepatocytes and hepatoma cell line. Hepatology 1:132-136.
48. Tolle, T. K., D. Glebe, M. Linder, D. Linder, S. Schmitt, R. Geyer, and W. H. Gerlich. 1998. Structure and glycosylation patterns of surface proteins from woodchuc k hepatitis virus. J. Virol. 72:9978-9985.
49. Tuttleman, J. S., J. C. Pugh, and J. W. Summers. 1986. In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus, J. Virol. 58:17-25.
50. Ulrich, P. P., R. A. Bhat, B. Seto, D. Mack, J. Sninsky, and G. N. Vyas. 1989. Enzymatic amplification of hepatitis B virus DNA in serum compared with infectivity testing in chimpanzees. J. Infect. Dis. 160:37-43.
51. Walter, E., R. Keist, B. Niederost, I. Pult, and H. E. Blum. 1996. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 24:1-5.
52. Waters, J. A., S. E. Brown, M. W. Steward, C. R. Howard, and H. C. Thomas. 1992. Analysis of the antigenic epitopes of hepatitis B surface antigen involved in the induction of a protective antibody response. Virus Res. 22:1-12.
53. Yan, R. Q., J. J. Su, D. R. Huang, Y. C. Gan, C. Yang, and G. H. Huang. 1996. Human hepatitis B virus and hepatocellular carcinoma. I. Experimental infection of tree shrews with hepatitis B virus. J. Cancer Res. Clin. Oncol. 122:283-288.
54. Young, M. D., D. L. Schneider, A. J. Zuckerman, W. Du, B. Dickson, and W. C. Maddrey. 2001. Adult hepatitis B vaccination using a novel triple antigen recombinant vaccine. Hepatology 34:372-376.